| Code | Description | Claims | Beneficiaries | Total Paid |
| J2778 |
Injection, ranibizumab, 0.1 mg |
296 |
166 |
$143K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
240 |
198 |
$116K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
872 |
618 |
$22K |
| 92134 |
|
1,077 |
835 |
$12K |
| J9035 |
Injection, bevacizumab, 10 mg |
111 |
86 |
$4K |
| J0178 |
Injection, aflibercept, 1 mg |
12 |
12 |
$4K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
50 |
38 |
$2K |
| 92250 |
|
152 |
75 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
18 |
12 |
$782.88 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
30 |
28 |
$759.37 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
26 |
12 |
$267.76 |